Blog
RSS FeedPosted by Michael Wonder on 14 Nov 2021
Regulating drug prices while increasing innovation
13 November 2021 - To save money on drugs while encouraging high-value pharmaceutical innovation, we need to better reward value, increase ...
Posted by Michael Wonder on 27 Oct 2021
FDA, NIH and 15 private organisations join forces to increase effective gene therapies for rare diseases
27 October 2021 - The U.S. FDA, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organisations have partnered ...
Posted by Michael Wonder on 13 Oct 2021
Why we can have both innovative drugs and lower drug prices
13 October 2021 - The debate in Congress over negotiating drug prices is based on a phony premise that higher prices ...
Posted by Michael Wonder on 11 Oct 2021
Tegsedi receives innovative drug category pricing in Brazil
11 October 2021 - PTC Therapeutics today announced that Tegsedi (inotersen) has successfully received Category 1 classification from Câmara de ...
Posted by Michael Wonder on 11 Oct 2021
Medicare drug pricing debate pits savings against innovation
11 October 2021 - Proposal to allow Medicare to negotiate for lower prescription drug prices is central to Democrats’ health care, ...
Posted by Michael Wonder on 14 Sep 2021
Biden drug pricing plan seeks to balance access and innovation
13 September 2021 - On Thursday 9 September, Health and Human Services Secretary Xavier Becerra publicly released the Biden Administration’s ...
Posted by Michael Wonder on 18 Aug 2021
Pharmaceutical companies should pay for raiding nature's medicine cabinet
11 August 2021 - In 2019, the pharmaceutical industry profited from US$1·2 trillion of global spending on medicines. Most of this ...
Posted by Michael Wonder on 31 Jul 2021
Making pharmaceutical companies report what matters about innovation
29 July 2021 - There is a lack of transparency about the cost of innovation of the pharmaceutical industry even ...
Posted by Michael Wonder on 22 Jul 2021
NHS England unveils new Innovative Medicine Fund
21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...
Posted by Michael Wonder on 12 Jul 2021
Teplizumab awarded Innovation Passport in the United Kingdom for the delay of onset of clinical type 1 diabetes in at risk individuals
12 July 2021 - Designation is the first step in a new MHRA initiative to accelerate the development and access to ...
Posted by Michael Wonder on 03 Jun 2021
Most Americans support Medicare negotiation despite claims it would hurt innovation
3 June 2021 - A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support ...
Posted by Michael Wonder on 14 May 2021
Making cancer treatments affordable today won’t hurt tomorrow’s innovation
12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...
Posted by Michael Wonder on 22 Apr 2021
New analysis shows international reference drug pricing would have a catastrophic impact on Alzheimer's disease research
22 April 2021 - Proposed policy would likely eliminate future clinical development programs in Alzheimer's research, impacting millions of patients and ...
Posted by Michael Wonder on 19 Apr 2021
NICE launches ambitious strategy to provide quicker access to new treatments and innovations
19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...
Posted by Michael Wonder on 12 Apr 2021
CBO report shows enacting drug pricing legislation will result in fewer new drugs
12 April 2021 - If there was a silver lining in the COVID-19 pandemic, it was the response of the biopharmaceutical ...